Columvi 2.5 mg

Columvi 2.5 mg is a solution containing Glofitamab, used for targeted therapy. This intravenous medication is manufactured by Hoffmann-La Roche Limited in Canada.

Columvi 2.5 mg is primarily used in the treatment of certain types of cancer. Glofitamab, the active ingredient, is designed to target specific cells in the body. Patients often wonder, 'What is Columvi used for?' This medication is typically prescribed for conditions where targeted therapy is beneficial.

Common effects of Columvi 2.5 mg may include infusion-related reactions, such as fever or chills. Some patients may experience fatigue or nausea. These effects can vary depending on individual health conditions and other factors.

Columvi 2.5 mg should be handled with care, as it is intended for intravenous use only. It is important to follow the instructions provided by healthcare professionals. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment.

Columvi 2.5 mg may interact with other medications, including those that affect the immune system. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also impact the effectiveness of this medication.